Discovery and Analysis of Patterns in Molecular Networks: Link Prediction, Network Analysis, and Applications to Novel Drug Target Discovery

Discovery and Analysis of Patterns in Molecular Networks: Link Prediction, Network Analysis, and Applications to Novel Drug Target Discovery

Bibliographic Details
Main Author:	Zhang, Minlu
Language:	English
Published:	University of Cincinnati / OhioLINK 2012
Subjects:	Computer Science network analysis link prediction transcriptional regulation orphan disease rare disease protein-protein interaction
Online Access:	http://rave.ohiolink.edu/etdc/view?acc_num=ucin1330024618

Similar Items

Efficient network based approaches for pattern recognition and knowledge discovery from large and heterogeneous datasets
by: Zhu, Cheng
Published: (2013)

Analysis of patient access to orphan drugs in Turkey
by: Güvenç Koçkaya, et al.
Published: (2021-02-01)

EVALUATION OF PHARMACISTS’ KNOWLEDGE AND ATTITUDES REGARDING RARE DISEASES AND ORPHAN DRUGS
by: Dušanka Krajnović, et al.
Published: (2013-01-01)

Application of network link prediction in drug discovery
by: Khushnood Abbas, et al.
Published: (2021-04-01)

A systematic review of moral reasons on orphan drug reimbursement
by: Bettina M. Zimmermann, et al.
Published: (2021-06-01)

Current Problems in Provision of Orphan Drugs and Ways to Solve Them
by: Alexei S. Kolbin, et al.
Published: (2016-09-01)

Disease awareness or subtle product placement? Orphan diseases featured in the television series “House, M.D.” - a cross-sectional analysis
by: Konstantin Mechler, et al.
Published: (2020-03-01)

Targeting transcription factors in cancer drug discovery
by: Partha Mitra
Published: (2020-12-01)

Using four decades of FDA orphan drug designations to describe trends in rare disease drug development: substantial growth seen in development of drugs for rare oncologic, neurologic, and pediatric-onset diseases
by: Kathleen L. Miller, et al.
Published: (2021-06-01)

Ethical Questions Linked to Rare Diseases and Orphan Drugs – A Systematic Review
by: Kacetl J, et al.
Published: (2020-10-01)

REASONS FOR DIFFICULTY OF THE PHARMACOECONOMIC ANALYSIS FOR ORPHAN DRUGS. WAYS FOR SOLUTIONS
by: Andrey Vladislavovich Pavlysh, et al.
Published: (2015-09-01)

Factors associated with positive and negative recommendations for cancer and non-cancer drugs for rare diseases in Canada
by: Fernanda Naomi Inagaki Nagase, et al.
Published: (2019-06-01)

Characteristics of drugs for ultra-rare diseases versus drugs for other rare diseases in HTA submissions made to the CADTH CDR
by: Trevor Richter, et al.
Published: (2018-02-01)

Estimating the clinical cost of drug development for orphan versus non-orphan drugs
by: Kavisha Jayasundara, et al.
Published: (2019-01-01)

Multi-Criteria Decision Analysis (MCDA) Models in Health Technology Assessment of Orphan Drugs—a Systematic Literature Review. Next Steps in Methodology Development?
by: Aleksandra Baran-Kooiker, et al.
Published: (2018-10-01)

An analysis of orphan medicine expenditure in Europe: is it sustainable?
by: Jorge Mestre-Ferrandiz, et al.
Published: (2019-12-01)

A Multi Criteria Approach for The Assessment of Drugs for Rare Diseases
by: Naili, Abdallah
Published: (2016)

Patient access to orphan drugs in France
by: Marion Bourdoncle, et al.
Published: (2019-02-01)

Can Standard Health Technology Assessment Approaches Help Guide the Price of Orphan Drugs in Canada? A Review of Submissions to the Canadian Agency for Drugs and Technologies in Health Common Drug Review
by: Balijepalli C, et al.
Published: (2020-08-01)

Expenditure trends of orphan drugs in Serbia: 8-Year analysis of orphan drug market in Serbia
by: Pejčić Ana V., et al.
Published: (2016-01-01)

Do payers value rarity? An analysis of the relationship between disease rarity and orphan drug prices in Europe
by: Goran Medic, et al.
Published: (2017-01-01)

Determinants of orphan drugs prices in France: a regression analysis
by: Daria Korchagina, et al.
Published: (2017-04-01)

Application of network link prediction in drug discovery
by: Abbas, K., et al.
Published: (2021)

Evaluating health policy and legal responses : how to reduce barriers and improve access to orphan drugs for rare diseases in Canada
by: Blais, Catherine-Marie
Published: (2016)

NORD. A beacon of hope for people with rare disorders
by: Stefanie Putkowski
Published: (2010-04-01)

A civil society view of rare disease public policy in six Latin American countries
by: Mo Mayrides, et al.
Published: (2020-02-01)

Orphan drugs for the pathogenetic treatment of rаre diseases in the drug registry
by: S. A. Mishinova
Published: (2019-04-01)

Rare Genetic Disorders: Novel Treatment Strategies and Insights Into Human Biology
by: Peter J. Koch, et al.
Published: (2021-08-01)

Orphan drug: Development trends and strategies
by: Aarti Sharma, et al.
Published: (2010-01-01)

A multi-stakeholder multicriteria decision analysis for the reimbursement of orphan drugs (FinMHU-MCDA study)
by: Fernando de Andrés-Nogales, et al.
Published: (2021-04-01)

Pattern Discovery in Protein Structures and Interaction Networks
by: Ahmed, Hazem Radwan A.
Published: (2014)

A comparative study of orphan drug prices in Europe
by: Katherine Eve Young, et al.
Published: (2017-01-01)

Comparative Analysis of Legislative Requirements About Patients' Access to Biotechnological Drugs for Rare Diseases in Central and Eastern European Countries
by: Maria Kamusheva, et al.
Published: (2018-07-01)

Exploring patient and family involvement in the lifecycle of an orphan drug: a scoping review
by: Andrea Young, et al.
Published: (2017-12-01)

Quantifying the persisting orphan-drug shortage public health crisis in the United States
by: Szymon Jarosławski, et al.
Published: (2017-01-01)

European and Italian regulation on orphan medicinal products
by: Roberta Joppi
Published: (2013-03-01)

Pharmacotherapeutic Patterns and Patients’ Access to Pharmacotherapy for Some Rare Diseases in Bulgaria – A Pilot Comparative Study
by: Maria Kamusheva, et al.
Published: (2021-07-01)

From Rare to Neglected Diseases: A Sustainable and Inclusive Healthcare Perspective for Reframing the Orphan Drugs Issue
by: Marialuisa Saviano, et al.
Published: (2019-03-01)

Pattern discovery for deciphering gene regulation based on evolutionary computation.
Published: (2010)

The work, goals, challenges, achievements, and recommendations of orphan medicinal product organizations in India: an interview-based study
by: Mohua Chakraborty Choudhury, et al.
Published: (2019-11-01)